Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001638599-18-000680

Options or other derivatives

  • Chief Scientific Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kishimoto Takashi Kei · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-06-15 Grant or award : show line 1 in the form Stock Option (Right to Buy) +50,000 $12.75 2028-06-14 50,000 50,000 D
Loading xslF345X03/doc4_5477.xml…